INDEPENDENT EVALUATION OF A MODIFIED-LIVE FELINE INFECTIOUS PERITONITIS VIRUS-VACCINE UNDER EXPERIMENTAL CONDITIONS (LOUISIANA EXPERIENCE)

Citation
Jd. Hoskins et al., INDEPENDENT EVALUATION OF A MODIFIED-LIVE FELINE INFECTIOUS PERITONITIS VIRUS-VACCINE UNDER EXPERIMENTAL CONDITIONS (LOUISIANA EXPERIENCE), Feline practice, 23(3), 1995, pp. 72-73
Citations number
NO
Categorie Soggetti
Veterinary Sciences
Journal title
ISSN journal
10576614
Volume
23
Issue
3
Year of publication
1995
Pages
72 - 73
Database
ISI
SICI code
1057-6614(1995)23:3<72:IEOAMF>2.0.ZU;2-T
Abstract
A temperature-sensitive, feline infectious peritonitis (FIP) vaccine w as evaluated in feline coronavirus naive, specific pathogen free cats. The vaccine was administered according to the manufacturer's instruct ions: two doses 3 to 4 weeks apart given to cats 16 weeks or older. No untoward side effects were observed and 50% of vaccinated cats were p rotected against challenge exposure to virulent FIP virus. Therefore, our study indicates that Primucell FIP(TM) has merit in protecting cat s from FIP under natural conditions.